ICU Medical Inc (ICUI) stock
ICUINasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 9/3032% above fair value
$177.30−0.96 (-0.54%)
Close on Nov 12, 2026Market cap $4.43BP/E 73.6Yield –
ICU Medical ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
ICU Medical's ebitda for the twelve months ending Sep 30, 2026 was $310.73M, up 11.9% year over year. For fiscal 2025 it was $243.57M, down 7.2% from the year before. Over ten years it grew 10.9% a year on average. The highest annual figure on record is $262.48M in fiscal 2024.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $243.57M | -7.2% |
| FY2024 | Dec 31, 2024 | $262.48M | +4.3% |
| FY2023 | Dec 31, 2023 | $251.60M | +30.9% |
| FY2022 | Dec 31, 2022 | $192.25M | -9.7% |
| FY2021 | Dec 31, 2021 | $212.94M | +15.9% |
| FY2020 | Dec 31, 2020 | $183.79M | -0.3% |
| FY2019 | Dec 31, 2019 | $184.28M | +76.4% |
| FY2018 | Dec 31, 2018 | $104.49M | +96.1% |
| FY2017 | Dec 31, 2017 | $53.28M | -47.8% |
| FY2016 | Dec 31, 2016 | $101.99M | +17.7% |
| FY2015 | Dec 31, 2015 | $86.64M | +48.1% |
| FY2014 | Dec 31, 2014 | $58.48M | -18.2% |
| FY2013 | Dec 31, 2013 | $71.46M | -11.0% |
| FY2012 | Dec 31, 2012 | $80.28M | -3.9% |
| FY2011 | Dec 31, 2011 | $83.52M | +28.5% |
| FY2010 | Dec 31, 2010 | $65.00M | +27.2% |
| FY2009 | Dec 31, 2009 | $51.10M | +12.0% |
| FY2008 | Dec 31, 2008 | $45.60M | +25.1% |
| FY2007 | Dec 31, 2007 | $36.44M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $101.92M | +58.0% |
| Q2 FY2026 | Jun 30, 2026 | $88.74M | +47.3% |
| Q1 FY2026 | Mar 31, 2026 | $63.61M | +2.0% |
| Q4 FY2025 | Dec 31, 2025 | $56.46M | -37.7% |
| Q3 FY2025 | Sep 30, 2025 | $64.52M | +1.0% |
| Q2 FY2025 | Jun 30, 2025 | $60.25M | -4.4% |
| Q1 FY2025 | Mar 31, 2025 | $62.33M | +38.9% |
| Q4 FY2024 | Dec 31, 2024 | $90.68M | +101.6% |
| Q3 FY2024 | Sep 30, 2024 | $63.91M | -21.3% |
| Q2 FY2024 | Jun 30, 2024 | $63.01M | +4.6% |
| Q1 FY2024 | Mar 31, 2024 | $44.87M | -31.1% |
| Q4 FY2023 | Dec 31, 2023 | $44.98M | -20.5% |
| Q3 FY2023 | Sep 30, 2023 | $81.22M | +39.6% |
| Q2 FY2023 | Jun 30, 2023 | $60.26M | -9.4% |
| Q1 FY2023 | Mar 31, 2023 | $65.14M | +493.4% |
| Q4 FY2022 | Dec 31, 2022 | $56.59M | +20.5% |
| Q3 FY2022 | Sep 30, 2022 | $58.17M | -4.0% |
| Q2 FY2022 | Jun 30, 2022 | $66.51M | +17.4% |
| Q1 FY2022 | Mar 31, 2022 | $10.98M | -77.5% |
| Q4 FY2021 | Dec 31, 2021 | $46.96M | -3.4% |
| Q3 FY2021 | Sep 30, 2021 | $60.63M | +29.0% |
| Q2 FY2021 | Jun 30, 2021 | $56.63M | +37.5% |
| Q1 FY2021 | Mar 31, 2021 | $48.73M | +3.6% |
| Q4 FY2020 | Dec 31, 2020 | $48.61M | +28.9% |
| Q3 FY2020 | Sep 30, 2020 | $46.99M | -9.8% |
| Q2 FY2020 | Jun 30, 2020 | $41.17M | -8.6% |
| Q1 FY2020 | Mar 31, 2020 | $47.01M | -4.9% |
| Q4 FY2019 | Dec 31, 2019 | $37.71M | +258.0% |
| Q3 FY2019 | Sep 30, 2019 | $52.09M | +143.2% |
| Q2 FY2019 | Jun 30, 2019 | $45.03M | -8.7% |
| Q1 FY2019 | Mar 31, 2019 | $49.45M | +113.0% |
| Q4 FY2018 | Dec 31, 2018 | $10.54M | -83.1% |
| Q3 FY2018 | Sep 30, 2018 | $21.42M | +54.0% |
| Q2 FY2018 | Jun 30, 2018 | $49.32M | – |
| Q1 FY2018 | Mar 31, 2018 | $23.22M | – |
| Q4 FY2017 | Dec 31, 2017 | $62.38M | +237.7% |
| Q3 FY2017 | Sep 30, 2017 | $13.90M | – |
| Q2 FY2017 | Jun 30, 2017 | -$17.62M | – |
| Q1 FY2017 | Mar 31, 2017 | -$5.39M | – |
| Q4 FY2016 | Dec 31, 2016 | $18.47M | – |
See a number that looks wrong?